Bio-Rad Laboratories (BIO) Receivables - Other (2013 - 2026)

Bio-Rad Laboratories (BIO) has 10 years of Receivables - Other data on file, last reported at $13.3 million in Q1 2026.

• On a quarterly basis, Receivables - Other fell 2.92% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $13.3 million, a 2.92% decrease from a year earlier, with the FY2025 full-year figure at $11.9 million, down 9.16% from the prior year.
• Receivables - Other for Q1 2026 stood at $13.3 million, up from $11.9 million in the prior quarter.
• Over the last five years, Receivables - Other for BIO reached as high as $14.8 million in Q1 2023 and fell as low as $6.3 million in Q2 2022.
• Historically, Receivables - Other has averaged $10.9 million across 5 years, with a median of $11.2 million in 2023.
• Across the five-year window, Receivables - Other soared 427.27% in 2022 and retreated 17.35% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $11.6 million in 2022, then climbed by 2.59% to $11.9 million in 2023, then rose by 10.08% to $13.1 million in 2024, then retreated by 9.16% to $11.9 million in 2025, then rose by 11.76% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $13.3 million in Q1 2026, $11.9 million in Q4 2025, and $9.5 million in Q3 2025.